Targeted delivery of salicylic acid from acne treatment products into and through skin: role of solution and ingredient properties and relationships to irritation. [2004.01]
Clinical evaluation of roxithromycin: a double-blind, placebo-controlled and crossover trial in patients with acne vulgaris. [2004.01]
Acne in ethnic skin: special considerations for therapy. [2004]
Clinical observation in 86 cases of acne vulgaris treated with Compound Oldenlandis Mixture. [2003.12]
Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle [2003.09]
Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. [2003.09]
Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents. [2003.09]
Compared efficacy and safety of tretinoin 0.1% microsphere gel alone and in combination with benzoyl peroxide 6% cleanser for the treatment of acne vulgaris. [2003.08]
New therapy update--A unique combination formulation in the treatment of inflammatory acne. [2003.07]
A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris. [2003.05]
Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. [2003.04]
Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline. [2003.03]
Antibiotic-resistant acne: lessons from Europe. [2003.03]
Acne: evolution of the clinical practice and therapeutic management of acne between 1996 and 2000. [2003.03]
The use of lymecycline in the treatment of moderate to severe acne vulgaris: a comparison of the efficacy and safety of two dosing regimens. [2003.01]
Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin. [2003.01]
Efficacy and safety of stabilised hydrogen peroxide cream (Crystacide) in mild-to-moderate acne vulgaris: a randomised, controlled trial versus benzoyl peroxide gel. [2003.01]
Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in the treatment of acne vulgaris: a randomized double-blind study. [2003.01]
Comedolysis by a lipohydroxyacid formulation in acne-prone subjects. [2003.01]
A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. [2003.01]
Topical acne drugs: review of clinical properties, systemic exposure, and safety. [2003]
The rationale for using a topical retinoid for inflammatory acne. [2003]
Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial. [2002.09]
Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial. [2002.09]
Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris. [2002.09]
A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women. [2002.08]
Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. [2002.07]
Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. [2002.06]
Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. [2002.05]
A randomized, parallel, vehicle-controlled comparison of two erythromycin/benzoyl peroxide preparations for acne vulgaris. [2002.05]
Treatment of acne by isotretinoin (general course) [2002.04.15]
The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. [2002.04]
Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. [2002.04]
Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy. [2002.03]
Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy. [2002.02]
Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial [2002.02]
A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. [2002.02]
The antibacterial activity of topical retinoids: the case of retinaldehyde. [2002.01]
Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. [2002.01]
Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. [2002]
Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. [2001.11]
Clindamycin phosphate 1% gel in acne vulgaris. [2001.11]
Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. [2001.10]
Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris [2001.10]
Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris. [2001.10]
Developments in topical retinoid therapy for acne. [2001.09]
A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. [2001.09]
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne [2001.08]
Acne scarring: a classification system and review of treatment options [2001.07]
Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. [2001.06]
<< Previous 1 2 3 4 Next >>
